Diapharma Consulting, Inc.
Doing business as Diapharma Group Inc.
- UEI
- NANFWFNAASE7
- CAGE
- 1LRC6
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- diapharma.com
- Founded
- 1997
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $14,088 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Bio / Data Corp | — | 334516 Analytical Laboratory Instrument Manufacturing |
| Chronolog Corp | Havertown, PA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Biorep Technologies, Inc. | Miami Lakes, FL | 339112 Surgical and Medical Instrument Manufacturing |
| Roka Bioscience | — | 334516 Analytical Laboratory Instrument Manufacturing |
| BDC Laboratories | Wheat Ridge, CO | 541330 Engineering Services |
About the company
Diapharma Consulting, Inc., doing business as Diapharma Group Inc., is a for-profit, Subchapter S corporation registered in the System for Award Management (SAM) since October 18, 2001, with current registration valid through February 4, 2025. The company appears to specialize in medical diagnostic and research equipment, specifically focusing on thrombosis and hemostasis-related technologies. Based on its federal contract awards, Diapharma provides specialized medical devices and diagnostic systems to civilian federal agencies, with a particular emphasis on advanced hemostatic response and thrombosis assessment technologies.
The company has secured multiple federal contract awards from civilian agencies, including the National Institutes of Health (NIH) Clinical Center, National Heart Lung and Blood Institute (NHLBI), and the Food and Drug Administration (FDA). Its contract awards demonstrate a consistent focus on providing sophisticated medical diagnostic equipment such as the Thrombodynamics T2-T Analyzer and the T-TAS (Thrombosis and Thrombotic Assay System) device. These contracts, ranging from $14,088 to $50,350, involve purchase orders for medical equipment and associated maintenance services. Notably, one contract with the FDA was designated as a Total Small Business set-aside, indicating the company's eligibility and participation in federal small business procurement programs. The contracts primarily involve supplying advanced medical diagnostic devices used for evaluating hemostatic responses, platelet function, and thrombosis-related research and clinical assessments.
Quick answers
Is Diapharma Consulting, Inc. registered in SAM.gov?
Diapharma Consulting, Inc.'s SAM.gov registration expired on June 12, 2026.
How much has Diapharma Consulting, Inc. received in federal contracts?
Federal contracts obligated $14,088 to Diapharma Consulting, Inc. in fiscal years 2023 through 2027.
What is Diapharma Consulting, Inc.'s most recent federal award?
Diapharma Consulting, Inc.'s most recent federal contract award is T-TAS diapharma group INC:1134907 [24-011473] (75N90024P00611), from NIH Clinical Center, on August 23, 2024.
On GovTribe
See Diapharma Consulting, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors